The first step in engaging HCPs is to make them aware of your medical product or treatment. According to OptimiseRX, 78% of HCPs prefer information on new treatments via digital channels like email, websites, and webinars. Clear communication of your mission and offerings helps build trust and engagement.
Medical Conferences & Events: As Ogilvy reports, 79% of HCPs attend conferences for clinical updates, making these events ideal for connecting, showcasing products, and building relationships.
Direct Mail & Email Campaigns: Post-COVID, email remains vital, with 65% of HCPs preferring email for product updates (HealthLink 2020). Personalized campaigns effectively communicate your value and boost awareness.
Digital advertising and social media: These channels effectively engage HCPs by dynamically communicating your mission and offerings to a wide audience.
Once HCPs are aware of a product, they evaluate its benefits, risks, and efficacy. During this stage, they research, consult peers, and seek expert opinions to make informed decisions. Pharma marketers can support them with resources such as:
Whitepapers and case studies: Highlight product efficacy, safety, and its role in the medical landscape.
Product demos and webinars: Showcase features and practical clinical applications.
CME programs: Keep HCPs updated on medical advancements and treatment options for better patient care.
In the decision-making stage, HCPs evaluate clinical evidence, outcomes, safety, and cost to choose suitable treatments. 86% of HCPs prefer data-driven content detailing product benefits, risks, and efficacy. Pharma marketers support this stage by providing key resources:
Advisory boards and expert panels: Offer insights on product development and strategies, fostering trust and informed decisions.
One-on-one consultations: Enable detailed discussions with physicians, supported by visual summaries to simplify complex information.